IDXG · ISSUER CIK 1054102
INTERPACE BIOSCIENCES, INC.
Between Aug 1, 2026 and Oct 29, 2026, 2 INTERPACE BIOSCIENCES, INC. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 202617:59 | Aug 20, 2026 | IDXG | CEO, President & Chairman, Director | M · Exercise | — | +1,966,763 | 2,037,645 | +2775% | — | ||
| Aug 20, 202617:59 | Aug 20, 2026 | IDXG | CEO, President & Chairman, Director | F · Tax | $1.61 | −581,718 | 1,455,927 | -29% | $937K | ||
| Aug 20, 202616:59 | Aug 20, 2026 | IDXG | CFO & COO | M · Exercise | — | +277,009 | 323,800 | +592% | — |